Slow-growing or nutritionally demanding live biotherapeutic strains can delay biomass generation, animal studies, and mechanism research. Creative Biolabs offers DoE-guided custom media optimization services to systematically screen carbon and nitrogen sources, trace elements, reducing agents, and pH ranges for your target strain. We deliver an optimized media composition, key factor analysis, scale-up considerations, and cost assessment points to support downstream fermentation and preclinical research.
Many live biotherapeutic candidates, especially fastidious or anaerobic strains, show slow growth or low biomass yield in standard laboratory media. This can delay animal studies, mechanism-of-action investigations, and other downstream research activities. Conventional one-factor-at-a-time optimization is often time-consuming and unable to capture interactions among nutrients and culture conditions. Our DoE-based media optimization service is designed to identify high-impact variables efficiently and build a strain-tailored formulation strategy for improved biomass generation.
Our DoE-based optimization service is designed to provide actionable, scalable, and economically viable solutions. We do not just hand you a recipe; we deliver a detailed optimization report. Upon completion of the project, clients receive a comprehensive data package detailing the following core deliverables:
| Output Category | Detailed Description | Impact on Your Project |
|---|---|---|
| Optimal Media Formula | The finalized, statistically guided concentrations of the ideal carbon/nitrogen sources, trace elements, reducing agents, and recommended pH window tailored specifically to your target strain. | Supports improved viable cell count and biomass generation for downstream in vivo studies. |
| Key Factor Contribution Analysis | Response surface plots and Pareto charts illustrating the statistical weighting and interaction effects of each media component on growth kinetics and viability. | Helps identify major nutritional drivers and interaction effects relevant to strain growth. |
| Scale-Up Feasibility Assessment | Evaluation of the optimized media's performance, providing preliminary scale-up considerations for flask-to-bioreactor transfer. | Helps reduce risk during process transfer. |
| Cost Evaluation Points | An economic analysis comparing the cost-efficiency of the optimized raw materials against standard formulations, focusing on industrial-grade alternatives where applicable. | Provides reference points for selecting media components with future scale-up cost in mind. |
We use a structured, data-driven methodology to navigate the complex multi-dimensional space of microbial nutrition, focusing on delivering practical results.
We establish baseline growth kinetics using standard media and identify candidate variables based on genomic insights, including diverse carbon, nitrogen, trace elements, and reducing agents.
We use statistically designed experiments, such as Plackett-Burman screening, to identify the media components with the strongest impact on strain growth and biomass output.
Using approaches like Response Surface Methodology (RSM), we map the interactions between the significant factors identified, pinpointing the concentration sweet spot for optimized growth.
The predicted optimized formulation is empirically tested in laboratory replicates to verify the model. Final adjustments to the recommended pH window and physical parameters are confirmed to provide practical outputs for scale-up review.
By evaluating multiple variables simultaneously through structured fractional factorial designs, we reduce the number of required experimental runs compared to traditional methods, saving development time.
Biological systems are highly interactive. Our DoE models capture and leverage the synergistic (or antagonistic) effects between different nutrients, a feat often missed by OFAT approaches.
Our team has experience supporting fastidious and anaerobic strains, including projects requiring reducing-agent screening and controlled redox-related culture conditions.
We prioritize scalable, industrial-grade raw materials during the screening phase, generating a detailed optimization report designed to help reduce risk during process transfer.
Statistical design approaches such as response surface methodology have been widely used to identify significant media components, quantify interaction effects, and improve microbial growth performance.
These studies support the value of replacing trial-and-error medium development with structured, data-driven optimization workflows. Creative Biolabs applies these principles to live biotherapeutic strains with project-specific screening and verification strategies, ensuring you achieve the high-yield biomass essential for your downstream applications.
Beyond media optimization, advancing a microbiome-based product requires an integrated suite of analytical and bioprocessing capabilities. Creative Biolabs provides end-to-end support to seamlessly transition your project from initial strain discovery through deep characterization and scalable fermentation, preparing you for rigorous in vivo modeling and clinical evaluation. Explore our recommended synergistic services below:
Traditional OFAT methods change only one nutrient variable at a time while holding others constant. This approach completely misses the interactions between variables—for instance, how a specific nitrogen source might only enhance growth if a certain trace metal is present. DoE uses statistical matrices to vary multiple factors simultaneously, revealing these critical synergistic or antagonistic interactions. This results in a statistically guided optimized formulation, rather than a false local maximum, while requiring significantly fewer experimental runs.
Project timelines vary depending on strain characteristics, baseline growth performance, and the number of factors included in the DoE workflow. A detailed timeline will be provided after project evaluation.
Yes. Our facilities and teams are highly specialized in handling strict anaerobes. For these projects, our DoE matrices expand beyond standard macronutrients to rigorously screen and optimize specific reducing agents (e.g., thioglycolate, L-cysteine), precisely defined trace elements portfolios, and oxidation-reduction potential (ORP) parameters essential for strict anaerobic metabolism.
Yes. During the variable selection phase, we prioritize scalable, industrial-grade raw materials (such as cost-effective complex peptones or yeast extracts) over analytical-grade lab reagents whenever possible. The final deliverable includes a cost evaluation point to provide practical inputs for cost-conscious media selection during future translational and clinical phases.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.